6515--NX EQ Infusion Pumps Multitherapy Ambulatory

Amendment to Combined Synopsis-Solicitation 36C10G25Q0081 0004 The purpose of this amendment is to: Extend the Due Date for the solicitation. The Due Date of the Combined Synopsis-Solicitation is extended to Monday, 06/23/2025 at 11:59 PM ET. /////////////////////////////////END OFAMENDMENT\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ .... Read More

Amendment to Combined Synopsis-Solicitation 36C10G25Q0081 0001 The purpose of this amendment is providing questions and answers to the RFQ. FDA Recalls and Safety History Consideration - In alignment with the VHA National Center for Patient Safety (NCPS) goals to promote patient safety, will the VA conduct or require an analysis of FDA recall data, safety alerts, MAUDE database adverse events, and historical safety performance for all proposed infusion pump models and manufacturers during the evaluation process? Answer to question a: SC#1 Must be FDA approved. Pre-Award Recall Screening Procedures Regarding the Combined Synopsis/Solicitation notice (page 11), how does .... Read More

Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice Page 7 of 7 Combined Synopsis/Solicitation Notice *= Required Field Combined Synopsis/Solicitation Notice Page 1 of 6 Solicitation Number: 36C10G25Q0081 Notice Type: Combined Synopsis/Solicitation Synopsis: COMBINED SYNOPSIS/SOLICITATION This is a combined synopsis/solicitation for brand name or equal commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a separate written solicitation .... Read More